IKK2 inhibitor
Catalog No. I03-901
Catalog No. | Pack Size | Price (USD) | |
---|---|---|---|
I03-901-10 | 10 mg | $90 | |
I03-901-50 | 50 mg | $360 | |
I03-901-BULK | BULK | Contact Us |
Overview:
Selective inhibitor of IKKbeta, IC50=11.2 uM. Inhibits transcription of NFkB-dependent genes in an IL-1beta-induced rheumatoid arthritis model (1). Displays anti-inflammatory activity. Reverses the anti-adipogenic effect of PDGF on human preadipocytes (2). Cell permeable and reversible.
References:
1. N Kishore et al. J. Biol. Chem. 2003 278:32861
2. A Gagnon et al. J. Endocrinol. 2009 201:75
CAS Registry Number:
354812-17-2
Molecular Formula:
C9H8N2OS2
Appearance:
Yellow powder
Melting Point:
209-211oC
Molecular Weight:
224.3
Purity:
>98% (TLC; 5% CH3OH in CH2Cl2; Rf=0.27); NMR (Conforms)
Solubilization:
May be dissolved in DMSO (25 mg/ml); Ethanol (2 mg/ml)
Aliases:
5-(Thien-3-yl)-3-aminothiophene-2-carboxamide
Storage and Stability:
Store desiccated as supplied at ambient temperature for up to 1 year. Store solutions at -20oC for up to 3 months.
Molecular Structure:
There are no related publications available for this product.
AKT/PKB Pathway, Apoptosis/Autophagy, Inflammation, p38 Pathway
STAY CONNECTED
Fax: 1-604-232-4601